{"name": "OvaScience",
 "permalink": "ovascience",
 "crunchbase_url": "http://www.crunchbase.com/company/ovascience",
 "homepage_url": "http://ovascience.com/",
 "blog_url": "http://www.facebook.com/OvaScience",
 "blog_feed_url": "",
 "twitter_username": "OvaScience",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@ovascience.com",
 "phone_number": "617-902-0682",
 "description": "A Privately-held Fertility Company",
 "created_at": "Wed Oct 12 06:41:56 UTC 2011",
 "updated_at": "Tue Jun 04 12:01:21 UTC 2013",
 "overview": "\u003Cp\u003EThe company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience\u00e2\u20ac\u2122s proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women\u00e2\u20ac\u2122s own cellular energy to improve egg quality. OvaScience was co-founded by Richard Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal M.D., Ph.D., of Longwood Founders Fund, along with fertility expert and Harvard Medical School Professor Jonathan Tilly, Ph.D. of Massachusetts General Hospital, and aging expert and Harvard Medical School Professor David Sinclair, Ph.D. The company is backed by leading life science investors Longwood Founders Fund and Bessemer Venture Partners. The company has assembled a world-class team of leading reproductive endocrinologists, embryologists, scientists and advisers to bring this technology to patients.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0015/7778/157778v3-max-150x150.jpg"],
     [[250,
       70],
      "assets/images/resized/0015/7778/157778v3-max-250x250.jpg"],
     [[331,
       93],
      "assets/images/resized/0015/7778/157778v3-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO and Co-Founder",
    "person":
     {"first_name": "Michelle",
      "last_name": "Dipp",
      "permalink": "michelle-dipp",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$82M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020111011e7ab0005l\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "OvaScience Tries To Improve IVF With $6M Series A ",
    "raised_amount": 6000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 10,
    "funded_day": 11,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/ovascience-grabs-37m-b-round-fertility-treatments/2012-04-03",
    "source_description": "OvaScience grabs $37M B round for fertility treatments",
    "raised_amount": 37000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "General Catalyst Partners",
         "permalink": "general-catalyst-partners",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0017/6425/176425v1-max-150x150.png"],
             [[240,
               57],
              "assets/images/resized/0017/6425/176425v1-max-250x250.png"],
             [[240,
               57],
              "assets/images/resized/0017/6425/176425v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bbt Capital Management",
         "permalink": "bbt-capital-management",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Cycad Group",
         "permalink": "cycad-group",
         "image":
          {"available_sizes":
            [[[131,
               150],
              "assets/images/resized/0018/2602/182602v1-max-150x150.jpg"],
             [[158,
               180],
              "assets/images/resized/0018/2602/182602v1-max-250x250.jpg"],
             [[158,
               180],
              "assets/images/resized/0018/2602/182602v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hunt BioVentures",
         "permalink": "hunt-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0018/2603/182603v1-max-150x150.jpg"],
             [[187,
               91],
              "assets/images/resized/0018/2603/182603v1-max-250x250.jpg"],
             [[187,
               91],
              "assets/images/resized/0018/2603/182603v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "RA Capital Management",
         "permalink": "ra-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0008/4805/84805v2-max-150x150.png"],
             [[230,
               58],
              "assets/images/resized/0008/4805/84805v2-max-250x250.png"],
             [[230,
               58],
              "assets/images/resized/0008/4805/84805v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2012/08/06/daily11-OvaScience-ups-most-recent-round-to-4M.html",
    "source_description": "OvaScience ups most recent round to $4M",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 7,
    "investments":
     []},
   {"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1544227/000154422713000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 34999920.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 28,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "The Prudential Tower ",
    "address2": "800 Boylston Street, Suite 1555 ",
    "zip_code": "02199",
    "city": "Boston",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        120],
       "assets/images/resized/0018/2598/182598v1-max-150x150.jpg"],
      [[250,
        200],
       "assets/images/resized/0018/2598/182598v1-max-250x250.jpg"],
      [[450,
        361],
       "assets/images/resized/0018/2598/182598v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}